4-Methoxy-3-((trimethylsilyl)ethynyl)pyridin-2-amine
CAS : 1142191-65-8
Ref. 3D-SVB19165
1g | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté | ||
2500mg | Arrêté |
Informations sur le produit
4-Methoxy-3-((trimethylsilyl)ethynyl)pyridin-2-amine (MTEP) is an organometallic compound that has been shown to have antiproliferative properties. It has been found to be effective in the treatment of cancer and can be used as an anticancer agent. MTEP is a covid-19 pandemic drug and is able to inhibit the growth of cancer cells by inhibiting DNA synthesis and transcription. MTEP also has anisotropic properties, which means that it reacts differently depending on the angle from which it is viewed.